You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 95 No. 1, JANUARY 1955 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (46)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

FECAL FLORA OF MAN AFTER ORAL ADMINISTRATION OF CHLORTETRACYCLINE OR OXYTETRACYCLINE

WEI-PING LOH, M.D., Ph.D.; EDGAR E. BAKER, Ph.D.

AMA Arch Intern Med. 1955;95(1):74-82.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

CONFLICTING reports have been published concerning the ability of chlortetracycline and oxytetracycline to reduce the bacterial population of the human intestinal tract. Some investigators consider these drugs useful for this purpose.* In contrast, other workers believe that administration of these antibiotics has only a minor effect on the intestinal flora.f Many of the published studies are concerned with a few fecal cultures on many patients or detailed cultural studies of only a few types of intestinal micro-organisms. The purpose of the present investigation is to make a detailed study of the effect of chlortetracycline and oxytetracycline on the intestinal flora of a few persons in the hope that some of the conflicting opinions may be resolved.

EXPERIMENTAL PROCEDURE

Sixteen normal healthy adult subjects of both sexes were given chlortetracycline orally for a period of five days in a daily dose of 1 gm. (250 mg. four times per day). Three . . . [Full Text PDF of this Article]


Author Affiliations

Indianapolis; Boston

From the Department of Microbiology, Boston University School of Medicine. Dr. Loh is at present assistant pathologist at the Indianapolis General Hospital.


Footnotes

This study was supported in part by a grant from Lederle Laboratories Division, American Cyanamid Company, Pearl River, N. Y.

Dr. Maxwell Finland, Boston City Hospital, and Dr. Henry Bakst, Boston University School of Medicine, gave access to a few experimental subjects.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1955 American Medical Association. All Rights Reserved.